Trifarotene
Brand names: Aklief Β· Active ingredient: Trifarotene
In short: AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
What is Trifarotene used for?
AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Trifarotene dosage
Apply a thin layer of AKLIEF Cream to the affected areas once daily, in the evening, on clean and dry skin.
One pump actuation should be enough to cover the face (i.e., forehead, cheeks, nose, and chin).
Two actuations of the pump should be enough to cover the upper trunk (i.e., reachable upper back, shoulders and chest). One additional pump actuation may be used for middle and lower back if acne is present.
The use of a moisturizer is recommended as frequently as needed from the initiation of treatment.
Avoid contact with the eyes, lips, paranasal creases, mucous membranes.
AKLIEF Cream is for topical use only. Not for oral, ophthalmic, or intravaginal use.
How to take Trifarotene β instructions & advice from the label
See FDA-approved patient labeling (Patient Information).
Advise the patient to:
Cleanse the area to be treated; pat dry. Apply AKLIEF Cream as a thin layer once daily in the evening to the face, avoiding the eyes, lips, nasolabial folds, and mucous membranes. A thin layer of AKLIEF Cream may also be applied to the chest, shoulders, and back.
Avoid applying AKLIEF Cream to damaged skin (such as cuts, abrasions), eczematous areas, and sunburned skin.
Reduce the risk of such irritation, use a moisturizer from the start of treatment, and, if appropriate, reduce the frequency of application of AKLIEF Cream or suspend use temporarily. AKLIEF Cream may cause irritation such as erythema, scaling, dryness, and stinging or burning.
Minimize exposure to sunlight, including sunlamps and phototherapy devices.
Use sunscreen products and protective apparel (e.g., hat) over treated areas when exposure to sunlight cannot be avoided.
Avoid concomitant use of other potentially irritating topical products (medicated or not).
Use AKLIEF Cream on the smallest area of skin and for the shortest duration possible while breastfeeding. β¦
Warnings & precautions
Do not take this medicine if: None
Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Maximum severity of these reactions typically occurred within the first 4 weeks of treatment, and severity decreased with continued use of the medication. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of application of AKLIEF Cream, or suspend use temporarily. If severe reactions persist the treatment may be discontinued.
Avoid application of AKLIEF Cream to cuts, abrasions, or eczematous or sunburned skin. Use of βwaxingβ as a depilatory method should be avoided on skin treated with AKLIEF Cream.
Minimize unprotected exposure to ultraviolet rays (including sunlight and sunlamps) during treatment with AKLIEF Cream. Warn patients who normally experience high levels of sun exposure and those with inherent sensitivity to sun to exercise caution. Use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided.
Trifarotene side effects
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect rates observed in practice. In the three Phase 3 clinical trials, 1673 subjects with acne vulgaris on the face and trunk, 9 years and older were exposed to AKLIEF Cream. Of these, 1220 subjects were treated once daily for up to 12 weeks and 453 were treated once daily for up to 1 year.
Adverse reactions reported in the 2 randomized, double-blind, vehicle-controlled 12-week clinical trials in
β₯1.0% of subjects treated with AKLIEF Cream (and for which the rate exceeded the rate for vehicle), as well as the corresponding rates reported in subjects treated with the vehicle cream are presented in Table 1.
Preferred Term | AKLIEF Cream
(N=1220) | Vehicle
Cream
(N=1200)
Application site irritation | 91 (7.5) | 4 (0.3)
Application site pruritus | 29 (2.4) | 10 (0.8)
Sunburn | 32 (2.6) | 6 (0.5)
Additional adverse reactions that were reported in more than one subject treated with AKLIEF Cream (and at a frequency <1%) included application site pain, application site dryness, application site discoloration, application site rash, application site swelling, application site erosion, acne, dermatitis allergic, and erythema. β¦
Drug interactions
Topical application of AKLIEF Cream is not expected to affect the circulating concentrations of oral hormonal contraceptives containing ethinyl estradiol and levonorgestrel.
About this medicine
AKLIEF Cream for topical administration contains 0.005% (50 mcg/g) trifarotene. Trifarotene is a terphenyl acid derivative and is a retinoid. The chemical name of trifarotene is 3β-tert-Butyl-4β-(2-hydroxy-ethoxy)-4β-pyrrolidin-1-yl-[1,1β,3β,1β]terphenyl-4- carboxylic acid. Trifarotene has the molecular formula of C
29H
33NO
4, the molecular weight of 459.58, and the following structural formula:
Trifarotene is a white to off-white to slightly yellow powder with the melting point of 245Β°C. It is practically insoluble in water with pKa1 of 5.69 and pKa2 of 4.55.
AKLIEF (trifarotene) Cream 0.005% contains the following inactive ingredients: allantoin, copolymer of acrylamide and sodium acryloyldimethyltaurate dispersion 40% in isohexadecane, cyclomethicone, 95% (v/v) ethanol, medium-chain triglycerides, phenoxyethanol, propylene glycol, purified water.
How it works: Trifarotene is an agonist of retinoic acid receptors (RAR), with particular activity at the gamma subtype of RAR. β¦
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 62d910db-85a6-4696-b69b-4bd2f3080cfc. Read the full official label on DailyMed.
Related medicines
Doxycycline Adalimumab Ketoconazole Levocetirizine Cyclosporine Tretinoin Brimonidine Dupilumab